Amyloid-beta clearance in Alzheimer's disease

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis a...

Descrición completa

Detalles Bibliográficos

Main Authors:	Robert Marr, Eliezer Masliah
Formato:	Online
Idioma:	inglés
Publicado:	Frontiers Media SA 2021
Subjects:	RC321-571 Q1-390 amyloid-beta Signal Transduction Proteases LDL receptors Clearance Alzheimer's disease thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences
Acceso en liña:	18589
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!